VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 4, 2015) -
NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA.
Premier Diagnostic Health Services Inc. ("Premier" or the "Company") (CSE:PDH), is pleased to announce that trading of its common shares has resumed, and it has received conditional approval of the Canadian Securities Exchange ("CSE") to its proposed change of business from a life sciences company to an investment company (the "Proposed COB" or "Change of Business"), as more particularly set out in Premier's news release dated March 2, 2015 and the management information circular dated March 3, 2015 which is posted on SEDAR at www.sedar.com and on Premier's website at www.premierdiagnostics.ca.
The Proposed COB remains subject to a number of conditions, including Shareholder approval and final approval of the CSE. There is no guarantee that either approval will be obtained.
On behalf of the Board of Directors
Sanjeev Parsad, President, CEO and Director
The Canadian Securities Exchange (CSE) has not reviewed the adequacy or the accuracy of the contents of this document. Company information can be viewed here: www.cnsx.ca. Further information regarding the Company can be found on SEDAR at ww.sedar.com.
Contact Information:
Sanjeev Parsad
President and CEO
(604) 678.9115 ext 205 or Cell: (604) 612.3965
(604) 678.9279 (FAX)
sparsad@premierdiagnostics.ca
www.premierdiagnostics.ca